Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Soluble IFNAR2 in Parkinson's disease and its role in the regulation of IFNβ in a neuroinflammatory context.

Periodic Reporting for period 1 - ParkIFNAR (Soluble IFNAR2 in Parkinson's disease and its role in the regulation of IFNβ in a neuroinflammatory context.)

Berichtszeitraum: 2020-09-14 bis 2022-09-13

An illustration summarizing the proposal
Mein Booklet 0 0